Skip to main content
. 2022 May 23;54(1):1520–1529. doi: 10.1080/07853890.2022.2077428

Table 3.

Multivariate linear regression model for the associations between the quartiles (Qs) of inflammatory markers and serum klotho level.

    Model 1 Model 2 Model 3
Uric acid
Q2 vs Q1 β coefficient (95% CI) −35.79 (−52.35, −19.22) −30.62 (−47.56, −13.68) −29.22 (−46.12, −12.32)
P-value <.001 <.001 <.001
Q3 vs Q1 β coefficient (95% CI) −65.72 (−82.32, −49.13) −58.47 (−76.29, −40.64) −55.30 (−73.10, −37.51)
P-value <.001 <.001 <.001
Q4 vs Q1 β coefficient (95% CI) −107.13 (−123.78, −90.48) −99.88 (−118.63, −81.14) −96.15 (−114.87, −77.43)
P-value <.001 <.001 <.001
CRP
Q2 vs Q1 β coefficient (95% CI) −7.74 (−30.79,15.32) −7.61 (−30.86,15.63) −7.52 (−30.70,15.67)
P-value .511 .521 .525
Q3 vs Q1 β coefficient (95% CI) −17.81 (−40.74,5.12) −19.05 (−42.65,4.54) −19.24 (−42.85,4.36)
P-value .128 .113 .110
Q4 vs Q1 β coefficient (95% CI) −39.69 (−62.79, −16.60) −49.53 (−74.53, −24.53) −50.30 (−75.39, −25.22)
P-value .001 <.001 <.001
WBC count
Q2 vs Q1 β coefficient (95% CI) −34.02 (−50.64, −17.40) −31.70 (−48.30, −15.11) −33.14 (−49.70, −16.59)
P-value <.001 <.001 <.001
Q3 vs Q1 β coefficient (95% CI) −38.51 (−55.04, −21.99) −35.75 (−52.36, −19.13 −37.71 (−54.34, −21.08)
P-value <.001 <.001 <.001
Q4 vs Q1 β coefficient (95% CI) −56.39 (−73.16, −39.63) −57.85 (−74.88, −40.81) −58.43 (−75.65, −41.21)
P-value <.001 <.001 <.001
MPV
Q2 vs Q1 β coefficient (95% CI) 11.64 (−5.04,28.32) 8.35 (−8.25,24.94) 7.56 (−8.97,24.12)
P-value .171 .324 .370
Q3 vs Q1 β coefficient (95% CI) 33.79 (17.01,50.57) 31.02 (14.31,47.72) 28.90 (12.24,45.56)
P-value <.001 <.001 .001
Q4 vs Q1 β coefficient (95% CI) 52.94 (36.09,69.79) 50.19 (33.39,66.99) 46.69 (29.93,63.47)
P-value <.001 <.001 <.001

Q1: Quartile 1; Q2: Quartile 2; Q3: Quartile 3; Q4: Quartile 4; CRP: C-reactive protein; WBC count: white blood cell count; MPV: mean platelet volume.

Model 1 = unadjusted.

Model 2 = adjusted for age, gender, body mass index, and race/ethnicity.

Model 3 = Model 2 + adjusted for history of angina, coronary heart disease, diabetes mellitus, hypertension, and smoking history.